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Diabetic ulceration of the foot is a major global 
medical, social and economic problem and is the most 
frequent end-point of diabetic complications. A 
retrospective analysis from February 2017 to May 
2019 of diabetic patients presenting below-the-knee 
artery disease (PAD) was carried out. Only patients 
treated with endovascular techniques as first choice 
treatment were evaluated.  Outcome measured was 
perioperative mortality and morbidity. Freedom from 
occlusion, secondary patency and amputation rate 
were all registered. Additional maneuvers including 
stenting or angioplasty with drug eluting balloon 
(DEB) were reported. A total of 167 (101 male/66 
female) patients with a mean age of 71 years were 
included in the study. A Rutherford 3, 4, 5 and 6 
categories were reported in 5, 7, 110 and 45 patients, 
respectively. No perioperative mortality was reported. 
Morbidity occurred in 4 (4.4%) cases and consisted of 
pseudoaneurysm. Additional stenting during first 
procedure was required in 7 (4%) patients, drug 
eluting balloon was needed in 56 (33%) patients. At 
1-year follow-up, estimated freedom from occlusion 
and secondary patency was 70% and 80% 
respectively. Major amputation rate was 2.4%, minor 
amputation rate was 41.9%. In our experience, 
extreme revascularization in search of distal direct 
flow reduce the rate of amputations with an increase 
in ulcer healing. New materials and techniques such 
as drug eluting technology, used properly, can 
improve outcome. 
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balloon angioplasty 
 
I.  INTRODUCTION 
 
Diabetic ulceration of the foot is a major global 
medical, social and economic problem and is the most 
frequent major end-point of diabetic complications. 
Diabetic neuropathy and peripheral vascular disease 
are the main etiological factors in foot ulceration and 
may act alone, together, or in combination with other 
factors such as microvascular disease, biomechanical 
abnormalities, limited joint mobility and increased 
susceptibility to infection.1 Diabetic foot patients are 
among the most complex and vulnerable of all 
diabetes patients; between 0.03% and 1.5% of patients 
with diabetic foot require an amputation.2 After major 
lower amputation the cumulative mortality rate at 
1 year was 30.7%.3 
 
II.  METHODS 
 
A retrospective analysis from February 2017 to May 
2019 of diabetic patients presenting below the knee 
artery disease (PAD) and diabetic foot was carried 
out. Patients treated with endovascular technique as 
first choice treatment during the observation period 
were included in the study. Simple PTA was 
performed in every procedure. Measured outcomes 
were perioperative mortality and morbidity. Freedom-
from-occlusion, secondary patency and amputation 
rate were all registered. Additional maneuvers 
including stenting or angioplasty with drug eluting 





A total of 167 (101 male//66 female) patients with a 
mean age of 71 years were included in the study. A 
Rutherford 3, 4, 5 and 6 class was reported in 5, 7, 110 
and 45 patients, respectively. Ulcers were identified 
according to Texas classification (grade I 48%, grade 
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II 33%, grade III 19%). No perioperative mortality 
was reported. Morbidity occurred in 4 (4,4%) cases 
and consisted of pseudoaneurysm. Additional stenting 
during first procedure was required in 7 (4%) patients 
and drug eluting balloon in 56 (33%) patients. 
Indication for stenting was arterial dissection; Drug 
eluting balloon was used for residual stenosis or recoil 
after first PTA. The mean follow-up was 12 months. 
At 1-year follow-up, estimated freedom-from-
occlusion and secondary patency was 70% and 80%, 
respectively; major amputation rate was 2.4%, minor 




Ulceration rarely results from a single pathology. The 
etiopathogenesis of diabetic foot disease is 
multifactorial encompassing three main factors 
namely, neuropathy, ischaemia and infection leading 
to tissue necrosis and ulcer formation. Other factors 
are foot biomechanics and weight bearing, peripheral 
vessel calcification, trauma, diabetic autonomic 
neuropathy and microangiopathy and diabetic skeletal 
disease.1,4  It is the interaction of these contributory 
causes which lead to the breakdown of the foot at 
risk.5 Thus Diabetic foot disease is an important 
problem challenging diabetologists, internists and 
surgeons who, in specialized diabetic foot clinics, 
should work together to coordinate revascularization 
procedures to aggressively treat infections and to 
manage medical comorbidities in a multidisciplinary 
forum.  
The role of the vascular surgeon in this pattern of 
events is to cooperate with in order to get the best 
outcome from revascularization procedures. The aim 
of such interventions is to increase the blood flow to 
the foot which in turn enhances cutaneous oxygen 
pressure promoting infection clearance and ulcer 
granulation at a crucial time point.6 Techniques such 
as subintimal angioplasty of the femoral-popliteal 
artery segment, retrograde angioplasty using trans-
pedal access and arterial flossing with anterograde-
retrograde intervention are several technical 
innovations that improve the percutaneous 
transluminal angioplasty success rate in the diabetic 
limb which, as open techniques, have the final 
outcome of increasing distal vascularization. Several 
studies have highlighted the importance of a deep 
revascularization in view of the fact that below the 
knee revascularization reduces the rate of non-
healing, minor and major amputations.7 Endovascular 
therapy plays a major role in the treatment of critical 
limb ischemia with below the knee arteries involved. 
New materials, unconventional techniques and the 
operator’s skill can improve the outcome. An 
important part is also played by devices like drug 
eluting balloons (DEB). In literature there are few 
studies on the advantages of using DEB in this district 
8,9 but in our experience a secondary Drug Coated 
balloon angioplasty, during first or following 
approach offers the advantages of simplicity and 
reduction in the need for stenting while increasing 
primary and secondary patency rates.10 
Another significant factor is the partnership between 
the different specialists such as diabetologist, 
cardiologist, general surgeon, plastic surgeon and 
others. This natural passage that complements the 
skills and knowledge of each attending physician 
would increase successful limb salvage and functional 
outcomes. The American Diabetes Association 
recommends, as well, a multidisciplinary approach 
for individuals with foot ulcers and those who are at 
high-risk of foot loss. In particular, the presence of a 
multidisciplinary team aimed at preventive care has 
been reported to decrease the risks associated with 
diabetic foot and amputation by 50% to 85%.11 
 
V.  CONCLUSION 
 
Extreme revascularization in search of distal direct 
flow reduces the rate of amputation and increases 
ulcer healing. The literature shows better outcomes, 
limb salvage and rate amputation reduction when a 
vascular surgeon is part of a multi-disciplinary 
treatment team.12 New materials, used properly, can 
improve the outcomes. 
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